Beck Bode’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$447K Buy
1,917
+166
+9% +$38.4K 0.07% 66
2026
Q2
$371K Buy
+1,751
New +$344K 0.06% 72
2021
Q4
– Sell
-3,132
Closed -$455K – 89
2021
Q3
$455K Buy
3,132
+60
+2% +$8.78K 0.13% 66
2021
Q2
$405K Buy
3,072
+991
+48% +$130K 0.11% 62
2021
Q1
$267K Buy
+2,081
New +$256K 0.08% 57
2020
Q4
– Sell
-1,781
Closed -$204K – 79
2020
Q3
$204K Buy
+1,781
New +$210K 0.07% 54

Other funds holding DGX

Beck Bode's DGX Position: Q3 2026 in Review

Beck Bode increased its Quest Diagnostics (DGX) stake by 9.5% in Q3 2026, buying an estimated $38.4K and bringing the position to 1,917 shares worth $447K. The position accounts for 0.07% of the portfolio, ranked #66.

Beck Bode first reported a position in DGX in Q3 2020 and has held it in 6 quarters since. The position peaked at $455K in Q3 2021. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Beck Bode held 1,917 shares of Quest Diagnostics worth $447K as of Q3 2026.
  • Beck Bode bought 166 Quest Diagnostics shares in Q3 2026, an estimated $38.4K.
  • Quest Diagnostics made up 0.07% of Beck Bode's portfolio in Q3 2026, its #66 holding.
  • Beck Bode first reported a position in Quest Diagnostics in Q3 2020 and has held it in 6 quarters since.
  • Beck Bode's Quest Diagnostics position peaked at $455K in Q3 2021.
  • 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.